AGMB
AgomAb TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
AGMB vs peer average
32/100
AGMB vs. peer average (D vs. C)
Grade spread
B 4 · C 3 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
TECX is the first available peer comparator.
Similar-sized clinical-stage biotech from the packet, but its programs differ. This is only a loose financing and trial-risk reference, not a direct operating or valuation peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AGMB
AgomAb Therapeutics
TECX
Tectonic Therapeutic
Grade
D
C
Momentum
4
8
Value
46
41
Sentiment
63
74
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs TECX
AGMB / TECX
Grade Position
Below peers
AGMB vs. peer average (D vs. C)
32/100
Momentum
4
TECXValue
46
AGMBSentiment
63
TECXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AGMB
TECX is the first peer returned for this comparison set.